Oxford Biomedica plc (OXB.L) LSE

Currency In GBp

AD

Valuation

Market Cap690.56M
Enterprise Value741.8M
P/E Ratio-18.42
PEG Ratio-0.54
Price/Sales Ratio3.77
Price/Book Ratio6.09
Enterprise/Revenue4.08
Enterprise/EBITDA-75.42

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterDecember 31, 2025

Profitability

Profit Margin-0.18
Operating Margin-0.18
AD

Management Effectiveness

Return On Assets-0.09
Return On Equity-0.49

Income Statement

Revenue168.74M
Revenue/Share1.59
Gross Profit65.98M
EBITDA-9.12M
Net Income-30.13M
Diluted EPS-0.27

Balance Sheet

Total Cash96.88M
Total Cash/Share0.92
Total Debt148.13M
Total Debt/Equity1.62
Current Ratio2.2
Book Value Per Share0.86

Price History

52-Week Change-2.95
52-Week High962
52-Week Low441.5
Moving Average 50 Days581.91
Moving Average 200 Days641.06

Statistics

Average Volume558,404
Shares Outstanding121.04M
% Held by Institutions3.14

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:50
Last Split DateMay 30, 2018
AD